These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38455972)

  • 1. The decreased astrocyte-microglia interaction reflects the early characteristics of Alzheimer's disease.
    Liu K; Aierken A; Liu M; Parhat N; Kong W; Yin X; Liu G; Yu D; Hong J; Ni J; Quan Z; Liu X; Ji S; Mao J; Peng W; Chen C; Yan Y; Qing H
    iScience; 2024 Mar; 27(3):109281. PubMed ID: 38455972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer's disease-related proteins.
    Rangaraju S; Dammer EB; Raza SA; Gao T; Xiao H; Betarbet R; Duong DM; Webster JA; Hales CM; Lah JJ; Levey AI; Seyfried NT
    Mol Neurodegener; 2018 Jun; 13(1):34. PubMed ID: 29954413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LPS priming before plaque deposition impedes microglial activation and restrains Aβ pathology in the 5xFAD mouse model of Alzheimer's disease.
    Yang Y; García-Cruzado M; Zeng H; Camprubí-Ferrer L; Bahatyrevich-Kharitonik B; Bachiller S; Deierborg T
    Brain Behav Immun; 2023 Oct; 113():228-247. PubMed ID: 37437821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neuroprotective N-terminal amyloid-β core hexapeptide reverses reactive gliosis and gliotoxicity in Alzheimer's disease pathology models.
    Lantz MJ; Roberts AM; Delgado DD; Nichols RA
    J Neuroinflammation; 2023 May; 20(1):129. PubMed ID: 37245024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of the astrocyte-neuron interaction is responsible for the impairments in learning and memory in 5XFAD mice: an Alzheimer's disease animal model.
    Choi M; Lee SM; Kim D; Im HI; Kim HS; Jeong YH
    Mol Brain; 2021 Jul; 14(1):111. PubMed ID: 34246283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intact olfactory memory in the 5xFAD mouse model of Alzheimer's disease from 3 to 15 months of age.
    O'Leary TP; Stover KR; Mantolino HM; Darvesh S; Brown RE
    Behav Brain Res; 2020 Sep; 393():112731. PubMed ID: 32522622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 14,15-Epoxyeicosatrienoic Acid Alleviates Pathology in a Mouse Model of Alzheimer's Disease.
    Chen W; Wang M; Zhu M; Xiong W; Qin X; Zhu X
    J Neurosci; 2020 Oct; 40(42):8188-8203. PubMed ID: 32973044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological expression of mutated TAU impaired astrocyte activity and exacerbates β-amyloid pathology in 5xFAD mice.
    Farfara D; Sooliman M; Avrahami L; Royal TG; Amram S; Rozenstein-Tsalkovich L; Trudler D; Blanga-Kanfi S; Eldar-Finkelman H; Pahnke J; Rosenmann H; Frenkel D
    J Neuroinflammation; 2023 Jul; 20(1):174. PubMed ID: 37496076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astrocyte Transforming Growth Factor Beta 1 Protects Synapses against Aβ Oligomers in Alzheimer's Disease Model.
    Diniz LP; Tortelli V; Matias I; Morgado J; Bérgamo Araujo AP; Melo HM; Seixas da Silva GS; Alves-Leon SV; de Souza JM; Ferreira ST; De Felice FG; Gomes FCA
    J Neurosci; 2017 Jul; 37(28):6797-6809. PubMed ID: 28607171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A selective p38α/β MAPK inhibitor alleviates neuropathology and cognitive impairment, and modulates microglia function in 5XFAD mouse.
    Gee MS; Son SH; Jeon SH; Do J; Kim N; Ju YJ; Lee SJ; Chung EK; Inn KS; Kim NJ; Lee JK
    Alzheimers Res Ther; 2020 Apr; 12(1):45. PubMed ID: 32317025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglia modulation with 1070-nm light attenuates Aβ burden and cognitive impairment in Alzheimer's disease mouse model.
    Tao L; Liu Q; Zhang F; Fu Y; Zhu X; Weng X; Han H; Huang Y; Suo Y; Chen L; Gao X; Wei X
    Light Sci Appl; 2021 Sep; 10(1):179. PubMed ID: 34493703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippocampal disruptions of synaptic and astrocyte metabolism are primary events of early amyloid pathology in the 5xFAD mouse model of Alzheimer's disease.
    Andersen JV; Skotte NH; Christensen SK; Polli FS; Shabani M; Markussen KH; Haukedal H; Westi EW; Diaz-delCastillo M; Sun RC; Kohlmeier KA; Schousboe A; Gentry MS; Tanila H; Freude KK; Aldana BI; Mann M; Waagepetersen HS
    Cell Death Dis; 2021 Oct; 12(11):954. PubMed ID: 34657143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ergothioneine, a dietary antioxidant improves amyloid beta clearance in the neuroretina of a mouse model of Alzheimer's disease.
    Wijesinghe P; Whitmore CA; Campbell M; Li C; Tsuyuki M; To E; Haynes J; Pham W; Matsubara JA
    Front Neurosci; 2023; 17():1107436. PubMed ID: 36998724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
    Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
    Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astrocytes from old Alzheimer's disease mice are impaired in Aβ uptake and in neuroprotection.
    Iram T; Trudler D; Kain D; Kanner S; Galron R; Vassar R; Barzilai A; Blinder P; Fishelson Z; Frenkel D
    Neurobiol Dis; 2016 Dec; 96():84-94. PubMed ID: 27544484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gossypetin ameliorates 5xFAD spatial learning and memory through enhanced phagocytosis against Aβ.
    Jo KW; Lee D; Cha DG; Oh E; Choi YH; Kim S; Park ES; Kim JK; Kim KT
    Alzheimers Res Ther; 2022 Oct; 14(1):158. PubMed ID: 36271414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-intensity interval training ameliorates Alzheimer's disease-like pathology by regulating astrocyte phenotype-associated AQP4 polarization.
    Feng S; Wu C; Zou P; Deng Q; Chen Z; Li M; Zhu L; Li F; Liu TC; Duan R; Yang L
    Theranostics; 2023; 13(10):3434-3450. PubMed ID: 37351177
    [No Abstract]   [Full Text] [Related]  

  • 19. PKR knockout in the 5xFAD model of Alzheimer's disease reveals beneficial effects on spatial memory and brain lesions.
    Tible M; Mouton Liger F; Schmitt J; Giralt A; Farid K; Thomasseau S; Gourmaud S; Paquet C; Rondi Reig L; Meurs E; Girault JA; Hugon J
    Aging Cell; 2019 Jun; 18(3):e12887. PubMed ID: 30821420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative proteomics reveals that PEA15 regulates astroglial Aβ phagocytosis in an Alzheimer's disease mouse model.
    Lv J; Ma S; Zhang X; Zheng L; Ma Y; Zhao X; Lai W; Shen H; Wang Q; Ji J
    J Proteomics; 2014 Oct; 110():45-58. PubMed ID: 25108202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.